Taken together, these data suggest that elevated cytoplasmic HuR could serve as a diagnostic biomarker of higher tumor grade and prognostic marker of poor clinical outcome in breast cancer, consistent with previous reports6. Here, ELAVL1 is linked to breast cancer.